
Vasodilators Global Market Report 2025
Description
Vasodilators Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on vasodilators market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Where is the largest and fastest growing market for vasodilators ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The vasodilators market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:1) By Type: Arterial Dilators; Venous Dilators; Mixed Dilators
2) By Drugs: Nitroglycerin; Alprostadil; Minoxidil; Sorbitrate; Other Drugs
3) By Indication: Hypertension; Angina; Heart Failure; Other Indications
4) By Route Of Administration: Oral; Parenteral; Other Routes Of Administration
5) By End User: Hospitals; Homecare; Specialty Centers; Other End Users
Subsegments:
1) By Arterial Dilators: Calcium Channel Blockers; Nitric Oxide Donors; Potassium Channel Activators
2) By Venous Dilators: Nitrates; Nitrites; Phosphodiesterase Inhibitors (PDE5 Inhibitors)
3) By Mixed Dilators: Alpha-Adrenergic Antagonists; Angiotensin II Receptor Blockers (ARBs); ACE Inhibitors (Angiotensin-Converting Enzyme Inhibitors)
Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; AbbVie Inc.; Novartis AG; Sanofi S.A.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
This report focuses on vasodilators market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for vasodilators ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The vasodilators market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Type: Arterial Dilators; Venous Dilators; Mixed Dilators
2) By Drugs: Nitroglycerin; Alprostadil; Minoxidil; Sorbitrate; Other Drugs
3) By Indication: Hypertension; Angina; Heart Failure; Other Indications
4) By Route Of Administration: Oral; Parenteral; Other Routes Of Administration
5) By End User: Hospitals; Homecare; Specialty Centers; Other End Users
Subsegments:
1) By Arterial Dilators: Calcium Channel Blockers; Nitric Oxide Donors; Potassium Channel Activators
2) By Venous Dilators: Nitrates; Nitrites; Phosphodiesterase Inhibitors (PDE5 Inhibitors)
3) By Mixed Dilators: Alpha-Adrenergic Antagonists; Angiotensin II Receptor Blockers (ARBs); ACE Inhibitors (Angiotensin-Converting Enzyme Inhibitors)
Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; AbbVie Inc.; Novartis AG; Sanofi S.A.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
200 Pages
- 1. Executive Summary
- 2. Vasodilators Market Characteristics
- 3. Vasodilators Market Trends And Strategies
- 4. Vasodilators Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
- 5. Global Vasodilators Growth Analysis And Strategic Analysis Framework
- 5.1. Global Vasodilators PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Vasodilators Market Growth Rate Analysis
- 5.4. Global Vasodilators Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Vasodilators Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Vasodilators Total Addressable Market (TAM)
- 6. Vasodilators Market Segmentation
- 6.1. Global Vasodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Arterial Dilators
- Venous Dilators
- Mixed Dilators
- 6.2. Global Vasodilators Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Nitroglycerin
- Alprostadil
- Minoxidil
- Sorbitrate
- Other Drugs
- 6.3. Global Vasodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hypertension
- Angina
- Heart Failure
- Other Indications
- 6.4. Global Vasodilators Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oral
- Parenteral
- Other Route Of Administration
- 6.5. Global Vasodilators Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Homecare
- Speciality Centres
- Other End Users
- 6.6. Global Vasodilators Market, Sub-Segmentation Of Arterial Dilators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Calcium Channel Blockers
- Nitric Oxide Donors
- Potassium Channel Activators
- 6.7. Global Vasodilators Market, Sub-Segmentation Of Venous Dilators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Nitrates
- Nitrites
- Phosphodiesterase Inhibitors (PDE5 Inhibitors)
- 6.8. Global Vasodilators Market, Sub-Segmentation Of Mixed Dilators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Alpha-Adrenergic Antagonists
- Angiotensin II Receptor Blockers (ARBs)
- ACE Inhibitors (Angiotensin-Converting Enzyme Inhibitors)
- 7. Vasodilators Market Regional And Country Analysis
- 7.1. Global Vasodilators Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Vasodilators Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific Vasodilators Market
- 8.1. Asia-Pacific Vasodilators Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Vasodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Vasodilators Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Vasodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China Vasodilators Market
- 9.1. China Vasodilators Market Overview
- 9.2. China Vasodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Vasodilators Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Vasodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India Vasodilators Market
- 10.1. India Vasodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Vasodilators Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Vasodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan Vasodilators Market
- 11.1. Japan Vasodilators Market Overview
- 11.2. Japan Vasodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Vasodilators Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Vasodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia Vasodilators Market
- 12.1. Australia Vasodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Vasodilators Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Vasodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia Vasodilators Market
- 13.1. Indonesia Vasodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Vasodilators Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Vasodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea Vasodilators Market
- 14.1. South Korea Vasodilators Market Overview
- 14.2. South Korea Vasodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Vasodilators Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Vasodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe Vasodilators Market
- 15.1. Western Europe Vasodilators Market Overview
- 15.2. Western Europe Vasodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Vasodilators Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Vasodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK Vasodilators Market
- 16.1. UK Vasodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Vasodilators Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Vasodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany Vasodilators Market
- 17.1. Germany Vasodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Vasodilators Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Vasodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France Vasodilators Market
- 18.1. France Vasodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Vasodilators Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Vasodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy Vasodilators Market
- 19.1. Italy Vasodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Vasodilators Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Vasodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain Vasodilators Market
- 20.1. Spain Vasodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Vasodilators Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Vasodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Vasodilators Market
- 21.1. Eastern Europe Vasodilators Market Overview
- 21.2. Eastern Europe Vasodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Vasodilators Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Vasodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia Vasodilators Market
- 22.1. Russia Vasodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Vasodilators Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Vasodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America Vasodilators Market
- 23.1. North America Vasodilators Market Overview
- 23.2. North America Vasodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Vasodilators Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Vasodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA Vasodilators Market
- 24.1. USA Vasodilators Market Overview
- 24.2. USA Vasodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Vasodilators Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Vasodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada Vasodilators Market
- 25.1. Canada Vasodilators Market Overview
- 25.2. Canada Vasodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Vasodilators Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Vasodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America Vasodilators Market
- 26.1. South America Vasodilators Market Overview
- 26.2. South America Vasodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Vasodilators Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Vasodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil Vasodilators Market
- 27.1. Brazil Vasodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Vasodilators Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Vasodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East Vasodilators Market
- 28.1. Middle East Vasodilators Market Overview
- 28.2. Middle East Vasodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Vasodilators Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Vasodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa Vasodilators Market
- 29.1. Africa Vasodilators Market Overview
- 29.2. Africa Vasodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Vasodilators Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Vasodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. Vasodilators Market Competitive Landscape And Company Profiles
- 30.1. Vasodilators Market Competitive Landscape
- 30.2. Vasodilators Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 31. Vasodilators Market Other Major And Innovative Companies
- 31.1. Bristol-Myers Squibb Company
- 31.2. Abbott Laboratories
- 31.3. GlaxoSmithKline Plc.
- 31.4. Eli Lilly and Company
- 31.5. Gilead Sciences Inc.
- 31.6. Amgen Inc.
- 31.7. AstraZeneca
- 31.8. Mayo Foundation for Medical Education and Research (MFMER)
- 31.9. Boehringer Ingelheim International GmbH
- 31.10. Bayer AG
- 31.11. Viatris Inc.
- 31.12. Novo Nordisk A/S
- 31.13. Teva Pharmaceutical Industries Ltd.
- 31.14. Astellas Pharma Inc.
- 31.15. Biogen
- 32. Global Vasodilators Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The Vasodilators Market
- 34. Recent Developments In The Vasodilators Market
- 35. Vasodilators Market High Potential Countries, Segments and Strategies
- 35.1 Vasodilators Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Vasodilators Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Vasodilators Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.